Epidermal growth factor (EGF) is a polypeptide mitogen of Mr =6,045 (3) . It binds to a specific cell surface receptor, is internalized-presumably as a complex with the receptor, is processed through intracellular organelles, and is degraded through a lysosomal pathway (3, 15, 21) . It is not yet clear whether internalization and intracellular processing are required to exert the mitogenic effects (1, 3, 15, 21) . In order to conduct a genetic study of the roles of the receptor-ligand interaction and intracellular processing in the mitogenic action of EGF (2, 9, 28) , it was necessary to devise a selection procedure for selecting genetic variants that are defective in receptor and/or postreceptor functions (26) . In the past few years, we and others have succeeded in constructing cytotoxic hybrid proteins that are highly potent and possess a selective specificity for cell surface receptors by replacing the binding moiety of a toxin, such as ricin or diphtheria toxin, with the ligand of interest (18) . We have applied this hybrid protein technique to a polypeptide hormone, insulin, and found that the insulin-toxin conjugates are valuable selection agents (12, 13, 14, 31) .
In this report, we have synthesized a conjugate between EGF and the catalytically active A subunit of ricin via a dithiopropionyl linkage according to the published method (4, 27, 30) . We have studied the cytotoxic activity of the conjugate and used it to isolate variants from Chinese hamster lung (CHL) cells. The initial characterization of several variants is described. A portion of this study has been reported elsewhere in abstract form (30 
DISCUSSION
In our previous work (29) , the catalytically active fragment of diphtheria toxin (DTa) was crosslinked with EGF. The resulting EGF-DTa conjugate was cytotoxic to human A431 cells at concentrations of 10-8 M, which is ten times less efficient than the EGF-RICa conjugate produced in this study. 
